// App-Quantinova.ai

O19 : Secukinumab-related gastrointestinal safety in PsA and AS

Researchers

Presenter

  • Ioana A Onac

Principal Investigators

  • Cristina Tacu

  • Benjamin D Clarke

  • Mark Lloyd

  • Vijey Hajela

  • Thomas Batty

  • Jamie Thoroughgood

  • Sandra Smith

  • Hannah Irvine

  • Diane Hill

  • Grace Baxter

  • Natalie Horwood

  • Suma Mahendrakar

  • Rizwan Rajak

  • Sian Griffith

  • Patrick Kiely

  • James B Galloway

Medical Centers

  • Rheumatology, Brighton and Sussex University Hospital, Brighton, UNITED KINGDOM

  • Academic Department of Rheumatology, King's College London, London, UNITED KINGDOM

  • Clinical Biochemistry, Frimley Park Hospital, Frimley, UNITED KINGDOM

  • Rheumatology, East Surrey Hospital, Redhill, UNITED KINGDOM

  • Audit Department, Royal Berkshire NHS Foundation Trust, Reading, UNITED KINGDOM

  • Rheumatology, St George's University Hospitals NHS Foundation Trust, London, United Kingdom

  • Rheumatology, Croydon University Hospital, Thornton Heath, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Substance Abuse

Disease

  • Opioid withdrawal syndrome

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved